From The Lead South Australia:
Blood testing technology developed by South Australian medical researchers is poised to transform the nutrition industry.
Trajan Nutrition CEO Marco Baccanti said, “Pathology labs can also now start using this methodology with far less invasive collection of blood of patients and using faster analytics and more cost effective techniques.”
University of Adelaide Professor of Functional Food Science Robert Gibson began work on the technology 10 years ago with Professor Maria Makrides.
“We are one of the leading labs now at developing the new dry blood spot tests for a variety of nutrients and compounds,” Prof Gibson said.
Read the full article: Blood spot tests set to replace costly vials
Trajan Scientific and Medical’s hemaPEN® has been independently evaluated and the results of the study published in the Royal Society of Chemistry’s journal Analyst - selected for the cover of issue 17. hemaPEN demonstrated significant advantages for blood sampling to support better healthcare decision making.
Trajan Scientific and Medical has listed its hemaPEN® blood microsampling device with the U.S. Food and Drug Administration as Class I for therapeutic and in vitro diagnostic use. This follows the hemaPEN’s recent registration in May for supply in the EU and UK as a General IVD; as well as inclusion in the TGA’s ARTG (Australian Register of Therapeutic Goods) in February as a Class I IVD.